Probable lecanemab-associated pontine hemorrhage following cardiovascular intervention: Clinical implications for lecanemab use
{{output}}
We report a 76-year-old patient with mild cognitive impairment and APOE ε3/ε3 genotype who developed a rare pontine hemorrhage following treatment with lecanemab, an anti-amyloid-β monoclonal antibody for Alzheimer's disease. She was initially on clopidogr... ...
